Capital Structure and Financial Performance of Listed Pharmaceutical Companies in Nigeria

Ezuma Smart Chinedu

doi:10.52589/AJAFR-G7KQBNCA

Capital Structure and Financial Performance of Listed Pharmaceutical Companies in Nigeria | AB Journals

Capital Structure and Financial Performance of Listed Pharmaceutical Companies in Nigeria

African Journal of Accounting and Financial Research

Vol. 5Issue 22022pp. 1–12Published 12 April 2022

DOI 10.52589/AJAFR-G7KQBNCA

2,286Views

764Downloads

Metrics

Share Link

𝕏

Cite this

Citation unavailable for this article.

Abstract:

This study investigated the relationship between capital structure and financial performance of listed pharmaceutical companies in Nigeria from 2013–2017. The ex post facto research design was adopted for the study with a population of ten (10) listed pharmaceutical companies in Nigeria as listed by the Nigerian Exchange Group in 2021. Data were retrieved from the annual reports of the selected listed pharmaceutical companies for the period 2013–2017. Multiple regression analysis was used to analyze the data gathered with the aid of Stata12 statistical software. The study revealed a positive and significant relationship between equity capital and profit before tax of listed pharmaceutical companies in Nigeria. It also revealed the existence of a positive and significant relationship between equity capital and return on assets of listed pharmaceutical companies in Nigeria. Therefore, it was recommended that the management of listed pharmaceutical companies in Nigeria should pay more attention to equity capital because it is a major determinant in enhancing profit before tax, and that equity capital should be encouraged so as to boast return of assets of listed pharmaceutical companies in Nigeria.

Keywords:Capital Structure Financial Performance Equity Capital Profit before Tax Return on Assets.

Copyrights

Authors retain copyright in their articles and have unrestricted rights to reuse, republish, archive, share, and distribute their work after publication.
All articles are published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including for commercial purposes, provided appropriate credit is given to the original author(s) and source.

Loading…

Disclaimer/Publisher’s Note

The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.